Jessica Matta

Company: Odimma therapeutics

Job title: Co-Founder & Chief Executive Officer & Chief Scientific Officer

Seminars:

Optimising DNA-Based Cancer Vaccines for Improved Immunogenicity 4:30 pm

• Developing neoantigen cancer vaccines based on DNA done at a very small scale • Addressing the reduced manufacturing time as the production process (there are a lot of benefits in quickly producing a vaccine per patient) • Utilising the benefits of adjuvants with DNA to induce strong cancer-specific immune responses • Currently in preclinical…Read more

day: Day One